- The World Health Organization’s International Agency for Research on Cancer estimates more than 35 million new cancer cases in 2050
- This represents a 77% increase from the estimated 20 million cancer cases that occurred in 2022
- WHO blamed the rising cancer rates on an aging population, along with tobacco, alcohol, obesity and exposure to air pollution
- WHO ignored the emergence of rapid-growing “turbo cancers” in people who have received one or more COVID-19 shots
- Many of these cancers are showing up in young people, many under age 30, with no family history of cancer; treatment protocols are available to help recover from post-jab injuries
(Mercola)—The World Health Organization’s International Agency for Research on Cancer (IARC) released a daunting prediction of the global cancer burden. It estimates more than 35 million new cancer cases in 2050 — a 77% increase from the estimated 20 million cancer cases that occurred in 2022.1
While WHO named an aging population as a key driver behind the increasing cancer burden, along with tobacco, alcohol, obesity and exposure to air pollution, what they’re ignoring is the concerning trend of turbo cancers that occur shortly after COVID-19 shots.
Cancer Cases Set to Increase Significantly by 2050
The IARC cancer burden estimates are based on the “best sources of data available in [185] countries in 2022.”2 That year, there were an estimated 20 million new cancer cases and 9.7 million deaths, with WHO reporting, “About 1 in 5 people develop cancer in their lifetime, approximately 1 in 9 men and 1 in 12 women die from the disease.”3
About two-thirds of the new cancer cases and deaths were caused by 10 types of cancer. Lung cancer was most common, followed by female breast cancer, colorectal cancer, prostate cancer and stomach cancer. When broken down by sex, breast cancer was the most commonly diagnosed — and the leading cause of cancer death — among women. For men, it was lung cancer.
Lung cancer and colorectal cancer accounted for the second and third most diagnosed types and cause of most deaths among women. However, for men, prostate and colorectal cancers were second and third most common, while liver and colorectal cancer caused the second and third most cancer deaths.4
There were also disparities revealed based on human development index (HDI), a statistical tool that assesses three dimensions of human development: a long and healthy life, access to knowledge (schooling) and a decent standard of living. According to WHO:5
“In terms of the absolute burden, high HDI countries are expected to experience the greatest absolute increase in incidence, with an additional 4.8 million new cases predicted in 2050 compared with 2022 estimates. Yet the proportional increase in incidence is most striking in low HDI countries (142% increase) and in medium HDI countries (99%). Likewise, cancer mortality in these countries is projected to almost double in 2050.”
What’s Driving Up Cancer Rates?
WHO blamed the projected cancer burden increase on a combination of age and environmental factors, stating:6
“The rapidly growing global cancer burden reflects both population ageing and growth, as well as changes to people’s exposure to risk factors, several of which are associated with socioeconomic development. Tobacco, alcohol and obesity are key factors behind the increasing incidence of cancer, with air pollution still a key driver of environmental risk factors.”
But it did not mention the emergence of rapid-growing cancers of the breast, colon, esophagus, kidney, liver, pancreas, bile duct, brain, lung and blood — including exceedingly rare types of cancer. As noted by Canadian oncologist and cancer researcher Dr. William Makis in the Highwire interview above,7 these cancers are showing up in young people, many under age 30, with no family history of cancer.
They’re showing up in pregnant women and young children. Equally odd is the fact that most are Stage 3 or 4 by the time they’re diagnosed, with symptoms arising only days or weeks before. The cancers grow and spread so rapidly, many of these patients die before treatment can even begin. Most of them are also resistant to conventional treatment.
The phenomenon has become common enough that the term “turbo cancers” was coined to describe these rapid-growing cancers in people who have received one or more COVID jabs.
Turbo Cancer Cases Reported Following COVID-19 Shots
In a case report described by board-certified internist and cardiologist Dr. Peter McCullough and colleagues, basaloid carcinoma, a type of aggressive cancer, developed in a 56-year-old man shortly after he received an mRNA COVID-19 shot.
Early symptoms, which began just four days after the jab, were similar to those caused by Bell’s palsy, and involved head pain — but soon a tumor developed on his ear and face. According to the study:8
“We place this within the context of multiple immune impairments potentially related to the mRNA injections that would be expected to potentiate more aggressive presentation and progression of cancer. The type of malignancy we describe suggests a population risk for occurrence of a large variety of relatively common basaloid phenotype cancer cells, which may have the potential for metastatic disease.
… Since facial paralysis/pain is one of the more common adverse neurological events following mRNA injection, careful inspection of cutaneous/soft tissue should be conducted to rule out malignancy.”
This is just one example. Another case report, published in Frontiers in Medicine,9 also found a “rapid progression” of angioimmunoblastic T-cell lymphoma (AITL) — a rare type of non-Hodgkin lymphoma (NHL) — following an mRNA COVID booster shot. AITL is a cancer that affects the lymph system, primarily involving T-cells, a type of white blood cell that plays a crucial role in the immune system.
“Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type,” the study notes.10
The cancer occurred in a 66-year-old man, mere days after he got his third Pfizer shot. Ironically, he got the shot to protect him during chemotherapy, and in eight days, the cancer just exploded and spread like wildfire.
According to Makis, that kind of progression would normally take a couple of years, or at least a few months. “Such a rapid evolution would be highly unexpected in the natural course in the disease,” according to the study.11
How Might COVID-19 Shots Trigger Cancer?
In May 2021, I interviewed Stephanie Seneff, Ph.D., a senior research scientist at MIT for over five decades, about the likely hazards of replacing the uracil in the RNA used in the COVID shots with synthetic methylpseudouridine.12 Uracil is one of the four nucleobases in the nucleic acid of RNA that are represented by the letters A, G, C and U.
This process of substituting letters in the genetic code is known as codon optimization, which is known to be problematic.
At the time, Seneff predicted the shots would cause a rise in prion diseases, autoimmune diseases, neurodegenerative diseases at younger ages, blood disorders and heart failure, and one of the primary reasons for this is because they genetically manipulated the RNA in the shots with synthetic methylpseudouridine, which enhances RNA stability by inhibiting its breakdown.
But when substituting parts of the code in this way, the resulting protein can easily get misfolded, and this has been linked to a variety of chronic diseases,13 including Alzheimer’s, Parkinson’s disease and heart failure.14 As explained by Makis, the pseudouridine insertion can also suppress your innate immune surveillance by dampening the activity of toll-like receptors, and one downstream effect of that is reduced cancer surveillance.
“The more mRNA shots you take, the greater the immune system damage, the greater your risk of impaired cancer surveillance and hence, the greater your risk of turbo cancer,” Makis says.
DNA Contamination Discovered in COVID Shots
In a preprint study, microbiologist Kevin McKernan — a former researcher and team leader for the MIT Human Genome project15 — and colleagues assessed the nucleic acid composition of four expired vials of the Moderna and Pfizer mRNA shots. “DNA contamination that exceeds the European Medicines Agency (EMA) 330ng/mg requirement and the FDAs 10ng/dose requirements” was found.16
So, in addition to the spike protein and mRNA in COVID-19 shots, McKernan’s team discovered simian virus 40 (SV40) promoters that, for decades, have been suspected of causing cancer in humans, including mesotheliomas, lymphomas and cancers of the brain and bone.17
Florida Surgeon General Dr. Joseph Ladapo, called for an end to the use of COVID-19 mRNA shots, citing concerns about DNA fragments in the products.18 In a December 6, 2023, letter sent to the U.S. Food and Drug Administration and Centers for Disease Control and Prevention, Ladapo outlined findings showing the presence of lipid nanoparticle complexes and the SV40 promoter/enhancer DNA.
While there are limits on how much DNA can be in a vaccine due to concern over DNA integration, the guidelines don’t consider lipid nanoparticles and other factors in COVID-19 shots that could enhance how much DNA can enter a cell.
“Lipid nanoparticles are an efficient vehicle for delivery of the mRNA in the COVID-19 vaccines into human cells and may therefore be an equally efficient vehicle for delivering contaminant DNA into human cells.
The presence of SV40 promoter/enhancer DNA may also pose a unique and heightened risk of DNA integration into human cells,” according to a news release from the Florida Department of Health (DOH).19 Further, according to the Florida DOH, the FDA’s own 2007 guidance states:20
- “DNA integration could theoretically impact a human’s oncogenes – the genes which can transform a healthy cell into a cancerous cell.
- DNA integration may result in chromosomal instability.
- The Guidance for Industry discusses biodistribution of DNA vaccines and how such integration could affect unintended parts of the body including blood, heart, brain, liver, kidney, bone marrow, ovaries/testes, lung, draining lymph nodes, spleen, the site of administration and subcutis at injection site.”
How to Recover From Post-Jab Injury
If you’ve had a COVID-19 shot, there are steps you can take to repair from the assault on your system. Remember, the more mRNA shots you take, the greater the immune system damage. So, the first step is to avoid getting anymore COVID jabs. Next, if you’ve developed any unusual symptoms, seek out help from an expert.
The Front Line COVID-19 Critical Care Alliance (FLCCC) also has a treatment protocol for post-jab injuries. It’s called I-RECOVER and can be downloaded from covid19criticalcare.com.21
Dr. Pierre Kory, who cofounded the FLCCC, has transitioned to treating the vaccine injured more or less exclusively. For more information, visit DrPierreKory.com. McCullough is also investigating post-jab treatments, which you can find on PeterMcCulloughMD.com.
The World Health Council has also published lists of remedies that can help inhibit, neutralize and eliminate spike protein, which most experts agree is a primary culprit. I covered these in my 2021 article, “World Council for Health Reveals Spike Protein Detox.”
- 1, 2, 3, 4, 5, 6 World Health Organization February 1, 2024
- 7 Rumble, The HighWire with Del Bigtree, Is the COVID Vaccine Causing Turbo Cancers? September 22, 2023
- 8 EXCLI Journal 2023;22:992-1011
- 9, 10 Frontiers in Medicine November 25, 2021; 8: 798095
- 11 Frontiers in Medicine November 25, 2021; 8: 798095, Discussion
- 12 International Journal of Vaccine Theory, Practice and Research May 10, 2021; 2(1): 402-444
- 13 Nature Medicine December 6, 2011; 17: 1536-1538
- 14 Autophagy August 2008; 4(6): 821-823
- 15 The Healthcare Channel April 2, 2024
- 16 OSF Preprints April 10, 2023
- 17 Expert Rev Respir Med October 2011; 5(5): 683-697
- 18, 19, 20 Florida Health January 3, 2024
- 21 Covid19criticalcare.com
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.